Publisher's Synopsis
This package includes volumes 1 and 2 in print of the fourth edition of The International Pharmacopoeia with the print version of the First Supplement and a CDROM which includes all volumes published to date with First, Second, Third and Fourth Supplements. This new edition of The International Pharmacopoeia consolidates the texts of the five separate volumes of the third edition. In preparing this consolidated edition the opportunity has been taken to review the General notices of the Pharmacopoeia. Certain additions and amendments have been made to the notices in order to clarify the interpretation of the Pharmacopoeia and to facilitate application of the requirements by the user.
The opportunity has also been taken to improve certain aspects of the layout and format of the publication. In this Fourth edition all the monograph texts are brought together in one section and the method texts in another. Each of these major sections are divided into appropriate sub-sections and the method texts are numbered for ease of cross-reference.
The first Supplement adds to and updates the texts of the fourth edition of The International Pharmacopoeia. The new CD-ROM contains the updated Fourth Edition of The International Pharmacopoeia, 2014. It comprises the two volumes published in 2006, the First, Second, Third and Fourth Supplements published in 2008, 2011, 2013 and 2014 respectively.
The International Pharmacopoeia includes a collection of recommended procedures for analysis and specifications for the determination of pharmaceutical substances, excipients and dosage forms intended to serve as source material for reference or adaptation by any World Health Organization (WHO) Member State wishing to establish pharmacopoeial requirements. The pharmacopoeia, or any part of it, shall have legal status, whenever a national or regional authority expressly introduces it into legislation. The International Pharmacopoeia is based on advice and decisions from the WHO Expert Committee on Specifications for Pharmaceutical Preparations. The support from the numerous experts, national quality control laboratories, institutions and pharmacopoeias, as well as WHO Collaborating Centers is gratefully acknowledged.
New and revised texts are introduced for eight monographs on active pharmaceutical ingredients, 15 monographs on finished pharmaceutical products, one general monograph, three methods of analysis and three texts for the section on Supplementary information.
